China Carves Niche in Pharma Outsourcing
With America caught up in a credit crunch causing the subprime lending crisis, August didn't seem a particularly good month to list on the New York Stock Exchange. No one told this to Wuxi Pharmatech, a Shanghai-based pharmaceuticals and biotechnology firm.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.